Core Insights - Option Care Health, Inc. announced preliminary unaudited financial results for Q4 and full year 2025, along with preliminary financial guidance for 2026 [1] Financial Results - Q4 2025 expected net revenue is projected between $1.46 billion and $1.47 billion, with GAAP net income between $59.1 million and $62.4 million, and adjusted diluted EPS between $0.46 and $0.49 [9] - Full year 2025 expected net revenue is projected between $5.645 billion and $5.655 billion, with GAAP net income between $208.2 million and $211.5 million, and adjusted diluted EPS between $1.72 and $1.76 [9] Financial Guidance - The company expects to provide further details regarding its full year 2026 financial guidance during the Q4 earnings call in February [3] Share Repurchase Program - The Board of Directors approved an increase in the share repurchase program authorization from $500 million to $1.0 billion, with no specified expiration date [4] - Approximately $95 million of shares were repurchased in Q4 2025, totaling approximately $307 million for the full year 2025 [5] Investor Engagement - Option Care Health will participate in the 44th Annual J.P. Morgan Healthcare Conference, with a presentation scheduled for January 13, 2026 [6]
Option Care Health Announces Preliminary Fourth Quarter & Full Year 2025 Financial Results and Preliminary Financial Guidance for Full Year 2026